ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

8.71

+0.79 (10.05%)

Sep 17, 2026, 11:33 AM EDT - Market open

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States Revenue	164.97M	113.01M	14.21M
Europe Revenue	820.00K	278.00K	531.00K
Revenue (Total)	165.79M	113.29M	14.75M

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Product Revenue	164.89M	112.98M	14.15M
Other Revenue	901.00K	306.00K	595.00K
Revenue (Total)	165.79M	113.29M	14.75M